MRI in children given gadodiamide injection: safety and efficacy in CNS and body indications

This publication has 10 references indexed in Scilit:

• Contrast-enhanced MRI of the central nervous system: Comparison between gadodiamide injection and gadolinium-DTPA
  Neuroradiology, 1995
• Safety Efficacy of Gadodiamide Injection Administered Intravenously to Children for Contrast-Enhanced MR of the Central Nervous System
  Academic Radiology, 1994
• Safety, Tolerance, and Pharmacokinetics of High Doses of Gadodiamide Injection, a Nonionic Magnetic Resonance Imaging Contrast Agent
  Academic Radiology, 1994
• Gadodiamide injection at 0.1 and 0.3 mmol/kg body weight: a phase III double-blind, parallel, randomised clinical investigation of known or suspected cenctral nervous system lesions at 1.5 T
  Neuroradiology, 1994
• Comparison of the safety of the standard dose and a higher dose of gadodiamide injection for MR imaging of the central nervous system
  Journal of Magnetic Resonance Imaging, 1994
• A double blind study to evaluate the tolerability of gadodiamide injection and its effect on renal function in patients undergoing cerebral magnetic resonance imaging
  The British Journal of Radiology, 1993
• Phase III multicenter clinical investigation to determine the safety and efficacy of gadoteridol in children suspected of having neurologic disease.
  Radiology, 1993
• A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system
  Neuroradiology, 1993
• Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media.
  Radiology, 1990
• Central nervous system lesions in pediatric patients: Gd-DTPA-enhanced MR imaging.
  Radiology, 1988